Impact of Obesity on Plasma Natriuretic Peptide Levels

Circulation

Volumn 109, Issue 5, 2004, Pages 594-600

  Wang, Thomas J ^a   Larson, Martin G ^e   Levy, Daniel ^b,c   Benjamin, Emelia J ^c   Leip, Eric P ^e   Wilson, Peter W F ^c   Vasan, Ramachandran S ^c,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d FRAMINGHAM HEART STUDY   (United States)

^e NONE

Author keywords

Epidemiology; Natriuretic peptides; Obesity

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CIRCULATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ATRIAL NATRIURETIC FACTOR; BODY CONSTITUTION; BODY MASS INDEX; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OBESITY; PROTEIN PRECURSORS;

EID: 1042267237     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000112582.16683.EA     Document Type: Article

References (32)

1. Hall JE. The kidney, hypertension, and obesity. Hypertension. 2003;41:625-633.
2. Lauer MS, Anderson KM, Kannel WB, et al. The impact of obesity on left ventricular mass and geometry: the Framingham Heart Study. JAMA. 1991;266:231-236.
3. Rocchini AP, Key J, Bondie D, et al. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med. 1989;321:580-585.
4. Landsberg L. Obesity and hypertension: experimental data. J Hypertens Suppl. 1992;10:S195-S201.
5. Dessi-Fulgheri P, Sarzani R, Tamburrini P, et al. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. J Hypertens. 1997;15:1695-1699.
6. Licata G, Volpe M, Scaglione R, et al. Salt-regulating hormones in young normotensive obese subjects: effects of saline load. Hypertension. 1994;23:120-124.
7. Sagnella GA, Markandu ND, Shore AC, et al. Raised circulating levels of atrial natriuretic peptides in essential hypertension. Lancet. 1986;1:179-181.
8. Buckley MG, Markandu ND, Miller MA, et al. Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. J Hum Hypertens. 1993;7:245-250.
9. Yano Y, Katsuki A, Gabazza EC, et al. Plasma brain natriuretic peptide levels in normotensive noninsulin-dependent diabetic patients with microalbuminuria. J Clin Endocrinol Metab. 1999;84:2353-2356.
10. Chattington PD, Anderson JV, Rees LH, et al. Atrial natriuretic peptide in type 2 diabetes mellitus: response to a physiological mixed meal and relationship to renal function. Diabet Med. 1998;15:375-379.
11. Kannel WB, Feinleib M, McNamara PM, et al. An investigation of coronary heart disease in families: the Framingham offspring study. Am J Epidemiol. 1979;110:281-290.
12. Sahn DJ, DeMaria A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-1083.
13. Wang TJ, Larson MG, Levy D, et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol. 2002;90:254-258.
14. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Bethesda, Md: National Heart, Lung, and Blood Institute: 1998.
15. Tobin J. Estimation of relationships for limited dependent variables. Econometrica. 1958;26:24-36.
16. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
17. Vaziri SM, Larson MG, Lauer MS, et al. Influence of blood pressure on left atrial size: the Framingham Heart Study. Hypertension. 1995;25:1155-1160.
18. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: John Wiley; 1989.
19. World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva, Switzerland: World Health Organization; 2002.
20. James SK, Lindahl B, Siegbahn A, et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO) -IV substudy. Circulation. 2003;108:275-281.
21. John SW, Krege JH, Oliver PM, et al. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science. 1995;267:679-681.
22. Tamura N, Ogawa Y, Chusho H, et al. Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci U S A. 2000;97:4239-4244.
23. Messerli FH, Ventura HO, Reisin E, et al. Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation. 1982;66:55-60.
24. Sarzani R, Paci VM, Dessi-Fulgheri P, et al. Comparative analysis of atrial natriuretic peptide receptor expression in rat tissues. J Hypertens Suppl. 1993;11(suppl 5):S214-S215.
25. Sarzani R, Dessi-Fulgheri P, Paci VM, et al. Expression of natriuretic peptide receptors in human adipose and other tissues. J Endocrinol Invest. 1996;19:581-585.
26. Sarzani R, Paci VM, Zingaretti CM, et al. Fasting inhibits natriuretic peptides clearance receptor expression in rat adipose tissue. J Hypertens. 1995;13;1241-1246.
27. Crandall DL, Ferraro GD, Cervoni P. Effect of experimental obesity and subsequent weight reduction upon circulating atrial natriuretic peptide. Proc Soc Exp Biol Med. 1989;191:352-356.
28. Sarzani R, Dessi-Fulgheri P, Salvi F, et al. A novel promoter variant of the natriuretic peptide clearance receptor gene is associated with lower atrial natriuretic peptide and higher blood pressure in obese hypertensives. J Hypertens. 1999;17:1301-1305.
29. Morabito D, Vallotton MB, Lang U. Obesity is associated with impaired ventricular protein kinase C-MAP kinase signaling and altered ANP mRNA expression in the heart of adult Zucker rats. J Invest Med. 2001;49:310-318.
30. Sengenes C, Berlan M, De Glisezinski I, et al. Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J. 2000;14:1345-1351.
31. Engei S, Sharma AM. The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension. J Mol Med. 2001;79:21-29.
32. Dessi-Fulgheri P, Sarzani R, Serenelli M, et al. Low calorie diet enhances renal, hemodynamic, and humoral effects of exogenous atrial natriuretic peptide in obese hypertensives. Hypertension. 1999;33:658-662.